Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

WIN 2019 Symposium /
Rapidly changing landscape of precision medicine in Japan

23rd - 24th Jun 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 10.07.19
Views: 276

Dr Sadakatsu Ikeda - Tokyo Medical and Dental University, Tokyo, Japan

Dr Sadakatsu Ikeda speaks to ecancer at the WIN 2019 Symposium in Paris about the rapidly changing landscape of precision medicine in Japan.

He explains that there has been recent approval for access to comprehensive genomic profiling in Japan, with between 5000 and 20,000 people per year expected to be available for this data capture.

Dr Ikeda also discusses the difficulties in accessing drugs following genomic sequencing due to the possible treatments being 'off-label'.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation